文献速递外周动脉疾病

可解释机器学习模型预测外周动脉疾病患者主要不良心血管事件

Interpretable machine learning prediction model for major adverse cardiovascular events in patients with peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2025-05-21

这项多中心回顾性研究纳入1558例外周动脉疾病患者,其中469例(30.1%)发生主要不良心血管事件(MACE)。研究构建并验证了基于梯度提升算法的可解释机器学习预测模型,内部验证AUC为0.864,外部验证AUC为0.777,并以网络计算器形式呈现。

要点

  • 梯度提升模型在内部验证中AUC为0.864,外部验证中AUC为0.777。
  • 关键预测因素包括多血管病变、脑血管病、糖化血红蛋白、C反应蛋白等八项。
  • SHAP框架和网络计算器增强了模型可解释性,可能帮助识别MACE风险。

核心结论

  • 梯度提升算法在预测外周动脉疾病患者MACE风险方面优于其他模型,外部验证证实其临床适用性。
  • SHAP框架和网络计算器增强了模型可解释性,使临床医生能更好理解促发MACE的因素。
  • 该工具可能帮助临床医生识别外周动脉疾病患者的MACE风险并更有效地实施预防措施。

研究设计与样本

  • 回顾性研究,纳入2022年1月至2023年12月期间入组的外周动脉疾病患者,随访于2024年12月完成。
  • 使用四个中心非重叠数据集:三个用于模型训练和内部验证,一个用于外部验证。
  • 模型开发数据集n=1110,外部验证数据集n=448,共纳入1558例患者。
  • 采用单因素分析、LASSO逻辑回归和随机森林算法进行特征选择,使用十种机器学习算法构建风险预测模型。
  • 主要结局MACE定义为心肌梗死、卒中和心血管死亡的复合终点,随访12至24个月。

主要发现

  • 1558例患者中469例(30.1%)发生MACE。
  • MACE发生率在训练队列为249/777(32.0%),内部验证队列为102/333(30.6%),外部验证队列为118/448(26.3%)。
  • 平均随访时间为19.0 ± 11.3个月,患者平均年龄73.1 ± 10.8岁,男性占70.0%(1091/1558)。
  • 梯度提升模型内部验证AUC为0.864(95% CI 0.822-0.905),外部验证AUC为0.777(95% CI 0.720-0.833)。
  • 关键预测因素包括多血管病变、脑血管病、糖化血红蛋白、C反应蛋白、白蛋白、外周动脉手术、冠心病和中性粒细胞。

关键数值与推荐

  • 梯度提升模型内部验证AUC为0.864(95% CI 0.822-0.905),外部验证AUC为0.777(95% CI 0.720-0.833)。
  • 模型纳入八个临床显著变量:多血管病变、脑血管病、糖化血红蛋白、C反应蛋白、白蛋白、外周动脉手术、冠心病、中性粒细胞。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为该工具可能帮助临床医生识别外周动脉疾病患者的MACE风险并更有效地实施预防措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Major adverse cardiovascular events (MACE) are severe complications of peripheral arterial disease (PAD), associated with a poor prognosis and disease burden. Therefore, the early identification of high-risk individuals is of paramount importance. This study aimed to develop and validate an interpretable machine learning (ML)-based prediction model for MACE risk in patients with PAD. METHODS: This retrospective study included patients with PAD enrolled between January 2022 and December 2023, with follow-up had been completed by December 2024. The primary outcome was MACE, defined as a composite of myocardial infarction, stroke, and cardiovascular mortality, and patients were followed up for 12-24 months using nonoverlapping datasets from four centers: three for model training and internal validation and one for external validation. Feature selection was performed using univariate analysis, least absolute shrinkage and selection operator logistic regression, and a random Forest algorithm. Ten different ML algorithms were used to construct the risk prediction model. Model performance was evaluated based on discrimination and calibration. The SHapley Additive exPlanations method was used to visualize model features and individual case predictions. The final risk prediction model was presented as a web-based calculator. RESULTS: This multicenter study involved both model development dataset (n = 1110) and external validation dataset (n = 448). Among the 1558 enrolled patients with PAD, 469 of 1558 patients (30.1%) experienced MACE. The incidence of MACE was higher in the training cohort (249/777 [32.0%]) compared with the internal validation cohort (102/333 [30.6%]) and external validation cohort (118/448 [26.3%]). The mean follow-up duration was 19.0 ± 11.3 months. Participants' mean age was 73.1 ± 10.8 years, with males comprising 70.0% of the patients (1091/1558). We developed ML models incorporating eight clinically significant variables, with Gradient Boosting demonstrating comparatively better performance by achieving area under the receiver operating characteristic curve values of 0.864 (95% confidence interval, 0.822-0.905) in internal validation cohort and 0.777 (95% confidence interval, 0.720-0.833) in external validation cohort. The key predictors included polyvascular disease, cerebrovascular disease, hemoglobin A1c, C-reactive protein, albumin, peripheral arterial surgery, coronary heart disease, and neutrophils. CONCLUSIONS: The Gradient Boosting algorithm outperformed other models in predicting MACE risk in patients with PAD, with external validation confirming its clinical applicability. The SHapley Additive exPlanations framework and web-based calculator enhanced the model's interpretability, enabling clinicians to better understand the factors contributing to MACE. This tool potentially helps clinicians to identify MACE risk in patients with PAD and implement preventive measures more effectively.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Song P, Liu X, Wang L, et al. Interpretable machine learning prediction model for major adverse cardiovascular events in patients with peripheral artery disease. J Vasc Surg. 2025. PMID: 40404022. doi:10.1016/j.jvs.2025.05.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。